Reporting side effects also helps to improve our understanding of medications and their safety
Our Retatrutide Raw Powder undergoes triple-stage HPLC/LC-MS testing at multiple production checkpoints, verifying purity exceeds 99.5% and confirming correct molecular structure
The FDA has a special program called "expanded access" (sometimes called compassionate use) for people who are seriously ill and have run out of options
A more serious concern with long term GLP-1RA usage relates to the potential increased risk for PDAC due to promoting cellular proliferation
Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted
PMID 38001271